Press release
Ophthalmic Drugs Market to reach USD 52.8 Bn in 2031, expanding at a CAGR of 6.2%: TMR Report
Ophthalmic Drugs
This growth is primarily fueled by the escalating prevalence of various eye disorders and diseases, including glaucoma, cataracts, macular degeneration, and diabetic retinopathy. Factors such as an aging population and shifting lifestyles contribute to the surge in eye conditions, driving demand for effective ophthalmic drugs for management and treatment. Additionally, increased healthcare expenditure and growing awareness regarding eye health further bolster the expansion of the global ophthalmic drugs market, underscoring the importance of addressing these pressing medical needs.
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ :
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1769&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR
๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ:
AbbVie, Inc., Alcon Vision LLC, Bausch Health Companies, Inc., Bayer AG, Coherus BioSciences, F. Hoffmann-La Roche Ltd., Novartis Pharmaceuticals Corporation, Pfizer, Inc., Regeneron Pharmaceuticals, Inc., Santen, Inc., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง:
Therapeutic Class
Anti-VEGF Agents
Anti-glaucoma Drugs
Alpha Agonist
Beta Blockers
Prostaglandin Analogs
Combined Medication
Others
Anti-inflammatory Drugs
Steroids
NSAIDs
Anti-infective Drugs
Anti-bacterial Drugs
Anti-fungal Drugs
Others
Anti-allergy Drugs
Others
Indication
Dry Eye
Glaucoma
Infection / Inflammation
Retinal Disorders
Wet AMD
Dry AMD
Diabetic Retinopathy
Others
Allergy
Uveitis
Others
Route of Administration
Topical
Local Ocular (intravitreal)
Others
Product Type
OTC
Prescription
Dosage Form
Eye Drops
Eye Solutions & Suspensions
Capsules & Tablets
Gels
Ointments
Others
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
๐๐๐ญ ๐๐ก๐ข๐ฌ ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐๐ฉ๐จ๐ซ๐ญ, ๐๐ง๐ฌ๐ญ๐๐ง๐ญ๐ฅ๐ฒ:
https://www.transparencymarketresearch.com/checkout.php?rep_id=1769<ype=S&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR
๐๐๐ฒ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ๐ฌ:
Inย April 2022,ย Sandoz, a Novartis division, announced the U.S. launch of the generic combination eyedrop brimonidine tartrate/timolol maleate ophthalmic solution 0.2%/0.5%, an AB-rated generic equivalent to AbbVie's COMBIGAN, to lower eye pressure in patients with ocular hypertension
Inย January 2022,ย F. Hoffmann-La Roche Ltd.ย received the U.S. Food and Drug Administration (FDA) approval for Vabysmo (faricimab-svoa) for the treatment of wet, or neovascular, age-related macular degeneration (AMD) and diabetic macular edema (DME)
Inย October 2021,ย the U.S. FDA approved AbbVie, Inc.'s Vuity (pilocarpine HCl ophthalmic solution) for the treatment of presbyopia. Vuity is the first and only eye drop to treat presbyopia, or age-related blurry near vision, in adults.
Inย September 2021,ย Teva Pharmaceuticals USA, Inc., an affiliate of Teva Pharmaceutical Industries Ltd., received an approval from the U.S. FDA for the first available generic version of AZOPT (brinzolamide ophthalmic suspension) 1% for the treatment of high pressure inside the eye due to ocular hypertension and open-angle glaucoma.
๐๐๐ ๐ข๐จ๐ง๐ฌ ๐๐จ๐ฏ๐๐ซ๐๐:
North America(USA, Canada and Mexico)
Europe(UK, Germany, France and the Rest of Europe)
Asia Pacific(China, Japan, India, and the Rest of the Asia Pacific region)
South America(Brazil, Argentina and the Rest of South America)
Middle East and Africa(GCC and Rest of the Middle East and Africa)
๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐ง๐๐ฌ:
Noteworthy trends include the adoption of novel drug delivery systems, rising demand for combination therapies, and increasing focus on personalized medicine approaches tailored to individual patient needs.
๐ ๐ฎ๐ญ๐ฎ๐ซ๐ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค:
The future of the ophthalmic drugs market appears promising, with continued research and development efforts expected to yield groundbreaking therapies and treatments for various eye conditions. Collaboration between pharmaceutical companies and research institutions is likely to drive innovation and accelerate market growth.
๐๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐ญ๐ฎ๐๐ฒ ๐๐จ๐ข๐ง๐ญ๐ฌ:
Epidemiological trends and prevalence rates of major eye diseases.
Regulatory landscape governing ophthalmic drugs.
Competitive analysis of major market players.
Market penetration strategies and expansion opportunities.
๐๐ซ๐จ๐ฐ๐ฌ๐ ๐๐จ๐ซ๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ฒ ๐๐๐:
๐๐ก๐จ๐ญ๐๐ซ๐๐ญ๐/๐๐ฉ๐ซ๐๐ฒ๐๐ ๐๐จ๐ง๐๐ซ๐๐ญ๐ ๐๐๐ซ๐ค๐๐ญ- https://www.globenewswire.com/news-release/2023/05/12/2668042/0/en/Shotcrete-Sprayed-Concrete-Market-is-expected-to-see-a-growth-of-7-during-the-forecast-period-2023-2031-Exclusive-Report-by-Transparency-Market-Research.html
๐๐จ๐ง-๐๐ง๐ฏ๐๐ฌ๐ข๐ฏ๐ ๐๐๐ฌ๐ญ๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ- https://www.globenewswire.com/news-release/2023/05/12/2667973/0/en/Non-Invasive-Testing-Market-Predicted-to-Grow-at-14-8-CAGR-from-2022-2031-as-per-TMR-Analysis.html
๐๐๐จ๐ฎ๐ญ ๐๐ซ๐๐ง๐ฌ๐ฉ๐๐ซ๐๐ง๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก
Transparency Market Research, a globalย market research companyย registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
๐๐จ๐ง๐ญ๐๐๐ญ:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website:ย https://www.transparencymarketresearch.comย ย ย ย ย ย
Email:ย sales@transparencymarketresearch.com
Follow Us:ย LinkedIn|ย Twitter|ย Blogย |ย YouTube
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ophthalmic Drugs Market to reach USD 52.8 Bn in 2031, expanding at a CAGR of 6.2%: TMR Report here
News-ID: 3404970 • Views: โฆ
More Releases from Transparency Market Research
Global Opioid Induced Constipation Treatment Market Set to Reach USD 5.2 Billion โฆ
The global opioid induced constipation (OIC) treatment market is witnessing steady and sustained growth as healthcare systems worldwide place increasing emphasis on comprehensive pain management and supportive care. Valued at US$ 2.9 billion in 2025, the market is projected to reach US$ 5.2 billion by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. Growth is primarily fueled by the rising prevalence of chronicโฆ
Pneumatic Flux Chipper Market Expanding at 7.4% CAGR Through 2036 - By Product T โฆ
The global Pneumatic Flux Chipper Market is set to witness sustained and resilient growth over the next decade, underpinned by expanding heavy manufacturing activities, rising welding and fabrication demand, and continuous investments in industrial infrastructure across emerging and developed economies. According to the latest industry analysis, the market was valued at US$ 760.5 Mn in 2025 and is projected to reach US$ 1,680.8 Mn by 2036, expanding at a compoundโฆ
AI in Automotive Market Outlook 2036: Global Industry to Surge from US$ 19.8 Bil โฆ
The AI in automotive market is entering a phase of exponential expansion, supported by rapid digitization of vehicles, growing safety mandates, and consumer demand for intelligent mobility. The global market was valued at US$ 19.8 Bn in 2025 and is projected to reach US$ 244.4 Bn by 2036, registering a remarkable CAGR of 27% from 2026 to 2036.
This growth trajectory reflects the transition of automobiles from mechanically driven products toโฆ
Hypodermic Needles Market to Reach US$ 7.9 Billion by 2036 on Rising Injectable โฆ
The global hypodermic needles market was valued at approximately US$ 4.2 billion in 2025 and is projected to reach around US$ 7.9 billion by 2036, expanding at a CAGR of nearly 5.8% from 2026 to 2036, driven by the rising prevalence of diabetes, cancer, and chronic diseases, growing demand for injectable drugs and biologics, and the expansion of global vaccination and immunization programs; increasing adoption of safety-engineered and disposable needles,โฆ
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcomingโฆ
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De โฆ
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeuticโฆ
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric โฆ
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550โฆ
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application โฆ
Market Study Report, LLC, has compiled an exhaustive research study of the โAlcohol Testing And Drug Testing Equipment marketโ, detailing every single market driver and intricately analyzing the business vertical. This โAlcohol Testing And Drug Testing Equipment marketโ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drugโฆ
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drugย Marketย From an insight perspective, the market report focuses on various levels of analyses โ industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.ย
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetesโฆ
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymeraseโฆ
